SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-17-357310
Filing Date
2017-11-30
Accepted
2017-11-30 16:10:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 8-A12B d497655d8a12b.htm 8-A12B 12541
  Complete submission text file 0001193125-17-357310.txt   13577
Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-38311 | Film No.: 171231400
SIC: 2836 Biological Products, (No Diagnostic Substances)